Galectin Therapeutics | GALT - Ebit





Ebit 変化する 日付
AbbVie USD 6.72B 1.99B 2026-06
Bristol-Myers Squibb USD 255M 44M 2026-09
Galectin Therapeutics USD -9.17M 163K 2023-09
Gilead Sciences USD 3.85B 1.17B 2026-06
Immunic USD -23.33M 2.67M 2025-12
Incyte USD -707.47M 1.41B 2026-09
Merck USD 7.33B 6.49B 2026-09